Analyzing key genetic and comorbid factors on the efficacy of digital therapeutics for treating high blood pressure

aDepartment of Medicine, Rowan University School of Osteopathic Medicine

bAmerican Preventive Screening & Education Association (APSEA), Stratford

cDepartment of Biology, Rutgers, the State University of New Jersey, New Brunswick

dDepartment of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA

Received 7 March 2023 Accepted 24 October 2023.

Correspondence to David F. Lo, MBS, Department of Medicine, Rowan School of Osteopathic Medicine, 1 Medical Center Dr, Stratford, NJ 08084, USA Tel: 973 996 8669; fax: 973 996 8668; e-mail: [email protected]

留言 (0)

沒有登入
gif